top of page
Dr. Holly Reeve
HydRegen
We tackle limitations with using biocatalysis at an early stage in industrial R&D, where agility, speed and predictability are essential, whilst also validating our scale up strategies with industry leaders, where cost, productivity and reproducibility are critical.
bottom of page